Abstract:Abstract The EGFR inhibitor Iressa has demonstrated strong preventive efficacy in the N-butyl-N-(4-hydroxybutyl)-nitrosamine (OH-BBN) model of bladder cancer in the rat. To explore its antitumor mechanism, we implemented a systems biology approach to characterize gene expression and signaling pathways in rat urinary bladder cancers treated with Iressa. Eleven bladder tumors from control rats, seven tumors from rats treated with Iressa and seven normal bladder epithelia were profiled using Affymetrix Rat Exon 1.0 ST Arrays. We identified 713 down-regulated and 641 up-regulated genes in comparing bladder tumors vs. normal bladder epithelia. In addition, 178 genes were down-regulated and 96 genes were up-regulated when comparing control tumors vs. Iressa-treated tumors. Two coexpression modules that were significantly correlated with tumor status and treatment status were identified (r = 0.70, P = 2.80 × 10−15 (bladder tumor vs. normal bladder epithelium) and r = 0.63, P = 2.00 × 10−42 (Iressa-treated tumor vs. control tumor), respectively). Both tumor module and treatment module were enriched for genes involved in cell cycle processes. Twenty-four and twenty-one highly connected hub genes likely to be key drivers in cell cycle were identified in the tumor module and treatment module, respectively. Analysis of microRNA genes on the array chips demonstrated that tumor module and treatment module were significantly associated with expression levels of let-7c (r = 0.54, P = 3.70 × 10−8 and r = 0.73, P = 1.50 × 10−65 respectively). These results suggest that let-7c down-regulation and its regulated cell cycle pathway may play an integral role in governing bladder tumor suppression or collaborative oncogenesis and that Iressa exhibits its preventive efficacy on bladder tumorigenesis by up-regulating let-7 and inhibiting the cell cycle. The identified hub genes may also serve as pharmacodynamic or efficacy biomarkers in clinical trials of chemoprevention in human bladder cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 818. doi:10.1158/1538-7445.AM2011-818

Experimental study on iressa inhibits the proliferation of gastric cancer SGC-7901 cells

Apoptosis of SGC7901 Gastric Cancer Cell Induced by Cyanidin-3-glucoside

Study on effect of cox-2 inhibitor on proliferation and invasion of human gastric cancer cells

[Effect of siRNA for mutant p53 gene on biological behavior of gastric cancer cell line SGC7901].

The Effect of Iressa on Proliferation of Breast Cancer Cells with Different Expression State of ER

Anti-proliferative and Apoptotic Effects of S1, a Tetrandrine Derivative, in Human Gastric Cancer BGC-823 Cells

Inhibitory effects of icaritin on proliferation of three human carcinoma cell lines

Study on the effect of proliferation and apoptosis of sarsasapogenin to human gastric cancer line BGC-823

Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer.

Abstract 818: Modulation of Gene Expression and Cell Cycle Signaling Pathways in Iressa-treated Urinary Bladder Cancer in Rats

Experimental Study of the Effect of Glycyrrhiza Flavonoids on Gastric Cancer in Vivo

[Inhibitory Effects of Iressa on Hepatocellular Carcinoma Hep-3B and HepG2 Cell Xenografts in Nude Mice].

Study on the Effect of HSP90 Inhibitor IPI-504 on Gastric Cancer Cells and Its Stem Cell Like Cells

Anticancer Effect of Icaritin on Human Lung Cancer Cells Through Inducing S Phase Cell Cycle Arrest and Apoptosis.

Effect of Isofebrifugine on the Proliferation and Invasion of Human Gastric Cancer Cells Via MMP.

Effects of quercetin on proliferation of gastric cancer lines SGC-7901 and the expression of HSP70 and EGFR

Effect of Gefitinib on Proliferation and Cell Cycle,apoptosis of A549 Cells

Effect of miR-582-3p on proliferation,migration and apoptosis of gastric cancer SGC-7901 cells in vitro

The Relation between the Expression of EGFR Family and The Effects ofIressa in Pancreatic Cancer Cell Lines

The effect of IRESSA on H22 mouse hepatocellular carcinoma

Effects of Rhizoma Paridis Pharmacologic Serum on Proliferation and Apoptosis of Human Gastric Carcinoma Cell Line SGC7901 in Vitro